Aptevo Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
18.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-1.77
|
0.00
|
1.77
|
100.00%
|
|
2022-12-31
|
-1.67
|
0.00
|
1.67
|
100.00%
|
|
2022-09-30
|
-1.64
|
-1.50
|
0.14
|
8.54%
|
|
2022-06-30
|
-1.33
|
5.58
|
6.91
|
519.55%
|
|
2022-03-31
|
-1.15
|
-1.55
|
-0.40
|
-34.78%
|
|
2021-12-31
|
-1.29
|
-1.27
|
0.02
|
1.55%
|
|
2021-09-30
|
-1.47
|
-1.43
|
0.04
|
2.72%
|
|
2021-06-30
|
-2.00
|
-1.75
|
0.25
|
12.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
2.53
|
|
2021-12-31
|
-6.09
|
|
2020-12-31
|
-5.23
|
|
2019-12-31
|
-14.98
|
|
2018-12-31
|
-33.46
|
|
2017-12-31
|
-6.59
|
|
2016-12-31
|
-0.78
|